At this junction,<unk>  is not a pharmaceutical target. As<unk>  is not overexpressed in cancer and is present throughout the body, so it is not considered a good target for most types of cancer drugs.<unk>  is expressed at very low levels through most of the body but at higher levels in many areas of the brain, particularly in dopamine neurons. Recently it has been shown that a sensitizing treatment regimen of amphetamines causes markedly increased levels of<unk>  and UNC-5 expression on neuron cell bodies. This may indicate that<unk> -1 receptors are involved in the lasting effects of exposure to stimulant drugs like amphetamine, and may have some therapeutic value in the field of drug tolerance.
Netrin receptor DCC
Thromboxane receptor
Fibroblast growth factor receptor 3
VCAM-1
Type II cytokine receptor
Type I cytokine receptor
Growth hormone secretagogue receptor
Low-density lipoprotein receptor gene family